An interventional study of RT3D-TEE-guided mitral valve repair in Degenerative Mitral Valve Disease, sponsored by Sheng Liu. Recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2022-10-28.
Sponsored by Sheng Liu · Not applicable, Interventional, and Treatment
The aim of this randomized controlled trial to investigate the effects of Real-time 3D transesophageal echocardiography (RT3D-TEE)-guided mitral valve repair on surgical failure and 1-year reoccurrence of mitral valve regurgitation in patients with degenerative mitral value disease.
535 studies on the registry are indexed under Heart Valve Diseases; 173 are open to participants now.
This study's planned enrollment of 338 is above the median of 100 across 291 interventional studies indexed under Heart Valve Diseases.
Browse Heart Valve Diseases studies →Sheng Liu is the lead sponsor of 4 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Two experienced surgeons and two experienced echocardiography technicians jointly formulated the plan for the TEE-guided mitral valve repair.
Procedure: RT3D-TEE-guided mitral valve repair
RT3D-TEE forms a surgical plan before surgery and 3 to 4 senior doctors with more than 50 cases of mitral valve repair perform the procedure.
Composite events of mitral valve repair failure and 1-year reoccurrence of mitral regurgitation
mitral valve repair failure, 1-year reoccurrence of mitral regurgitation
Time frame: 1 year
Individual occurrence of composite endpoints of mitral valve repair failure and 1-year reoccurrence of mitral regurgitation
Time frame: 1 year
The incidence of secondary transfer, perioperative complications
Time frame: 1 year
Intraoperative conditions including extracorporeal circulation time, aortic occlusion time
Time frame: 1 year
The recurrence rate of residual mitral valve regurgitation
Time frame: 1 year
Plan to share: Undecided
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sheng Liu